pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
the cabinet
Drugs
6,918
products tracked ·
6,918
matching
★ save view
↓
export CSV
search
phase
all
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
sort
catalysts
recent
name
therapeutic area
all
Oncology
1831
Infectious Disease
718
Cardiology
425
Pulmonology
396
Immunology
371
Ophthalmology
368
Dermatology
300
Women's Health
view
list
cards
Preclinical
NVPLC-2767
Metabolic Dysfunction-Associated Steatohepatitis (MASH or NASH)
NVP Healthcare Co Ltd
0
catalysts
Preclinical
NVX-101
rifampicin
Age Related Macular Degeneration
NeoVascularX Inc
0
catalysts
Phase 2
NVX-108
perflenapent
Glioblastoma Multiforme (GBM)
NuvOx Pharma LLC
0
catalysts
Phase 1
← prev
page 115 of 231
next →
131
Pain
89
Neurology
1
NX-1607
Adenocarcinoma Of The Gastroesophageal Junction
$NRIX
Nurix Therapeutics, Inc.
0
catalysts
Phase 2
NX-210c
Amyotrophic Lateral Sclerosis
Axoltis Pharma SAS
0
catalysts
Phase 1
NXP-900
Cervical Cancer
$NVCT
Nuvectis Pharma, Inc.
0
catalysts
NYPOZI TXID
NYPOZI TXID (FILGRASTIM-TXID)
Tanvex BioPharma USA Inc
0
catalysts
NYSTATIN AND TRIAMCINOLONE ACETONIDE
NYSTATIN AND TRIAMCINOLONE ACETONIDE (NYSTATIN AND TRIAMCINOLONE ACETONIDE)
SUN PHARMA CANADA
0
catalysts
NYSTATIN CREAM
NYSTATIN CREAM (NYSTATIN CREAM)
CROWN LABS INC
0
catalysts
NYVEPRIA
NYVEPRIA (PEGFILGRASTIM-APGF)
Hospira Inc
0
catalysts
Phase 2
NanoDOX
Wounds
Resilience Government Services Inc
0
catalysts
Preclinical
Nanoapalutamide
Prostate Cancer
Nanoform Finland Plc
0
catalysts
Preclinical
Nanoparticle Mesothelin MOTO-CAR
Solid Tumor
Thunder Biotech Inc
0
catalysts
Preclinical
Nephron Progenitor Cells (Auto)
Chronic Kidney Disease (Chronic Renal Failure)
Jikei University School of Medicine
0
catalysts
Preclinical
Nephron Progenitor Cells (Organ) (Allo iPS Cell-Based Induced)
Renal Failure
Sumitomo Pharma Co Ltd
0
catalysts
Phase 2
Nerofe
Refractory Acute Myeloid Leukemia
Immune System Key Ltd
0
catalysts
Phase 3
Neuronata-R
Amyotrophic Lateral Sclerosis
Corestemchemon Inc
0
catalysts
Preclinical
Next-generation CAR-T
Ovarian Cancer
ToolGen Inc
0
catalysts
Phase 1
Nezavist
Alcohol Use Disorder (AUD)
Lohocla Research Corp
0
catalysts
Preclinical
Niemann-Pick Type C
Niemann-Pick Disease Type C
U.S. National Institutes of Health
0
catalysts
Marketed
Nizoral
Ketoconazole Patriot (ketoconazole)
Pityriasis Simplex Capillitii (Dandruff)
Patriot Pharmaceuticals LLC
0
catalysts
Preclinical
No Alpha IL-2 Mutein
Unspecified Cancer
Roswell Park Cancer Institute
0
catalysts
Phase 2
Norovirus [strains Norwalk GI.1 + Sydney GII.4] (bivalent) vaccine
Norovirus Infections
$VXRT
Vaxart, Inc.
0
catalysts
Marketed
Norpace
Norpace (disopyramide phosphate)
Ventricular Arrhythmia
$PFE
PFIZER INC
0
catalysts
Phase 2
NouvNeu-001
Parkinson's Disease
iRegene Therapeutics Co Ltd
0
catalysts
Preclinical
NouvSight-001
Diabetic Retinopathy
iRegene Therapeutics Co Ltd
0
catalysts
Phase 2
Nov-DB2
Obesity
NovMetaPharma Co Ltd
0
catalysts
Preclinical
NovAD
Alzheimer's Disease
NovMetaPharma Co Ltd
0
catalysts
Phase 2
NovOB
Obesity
DNA gyrase
NovMetaPharma Co Ltd
0
catalysts
Preclinical
Novel Drug to Undisclosed Target
Crohn's Disease (Regional Enteritis)
$VIVS
VivoSim Labs, INC.
0
catalysts
